Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort.

García-Doval I, Pérez-Zafrilla B, Ferrandiz C, Carretero G, Daudén E, de la Cueva P, Gómez-García FJ, Herrera-Ceballos E, Belinchón-Romero I, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Rivera R, Vanaclocha F; BIOBADADERM Study Group.

J Dermatolog Treat. 2016;27(3):203-9. doi: 10.3109/09546634.2015.1088130. Epub 2015 Sep 25.

PMID:
26367799
2.

Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice.

Carrascosa JM, Garcia-Doval I, Pérez-Zafrilla B, Carretero G, Vanaclocha F, Daudén E, De la Cueva-Dobao P, Belinchón I, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Rivera R, Carazo C, Barboza L, Ferrándiz C; BIOBADADERM Study Group.

J Dermatolog Treat. 2015;26(6):502-6. doi: 10.3109/09546634.2015.1034070. Epub 2015 Apr 17.

PMID:
25886087
3.

Effects of consecutive trials and test-retest reliability of 1000-Hz tympanometry in adults.

Carazo CD, Sun XM.

Int J Audiol. 2015 Apr;54(4):241-8. doi: 10.3109/14992027.2014.955888. Epub 2014 Sep 29.

PMID:
25262790
4.

Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.

Carretero G, Ferrandiz C, Dauden E, Vanaclocha Sebastián F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina-Gibert M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Carazo C, Rivera R, Jiménez-Puya R, García-Doval I; BIOBADADERM Study Group.

J Eur Acad Dermatol Venereol. 2015 Jan;29(1):156-63. doi: 10.1111/jdv.12492. Epub 2014 Mar 31.

PMID:
24684267
5.

Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.

Carrascosa JM, Vilavella M, Garcia-Doval I, Carretero G, Vanaclocha F, Daudén E, Gómez-García FJ, Herrera-Ceballos E, De la Cueva Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Peral F, Torrado R, Rivera R, Jiménez-Puya R, Mendiola MV, Ferrándiz C; BIOBADADERM Study Group.

J Eur Acad Dermatol Venereol. 2014 Jul;28(7):907-14. doi: 10.1111/jdv.12208. Epub 2013 Jul 15.

PMID:
23848131
6.

Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain.

Román F, Roldán C, Trincado P, Ballesteros C, Carazo C, Vindel A.

Antimicrob Agents Chemother. 2013 May;57(5):2428-9. doi: 10.1128/AAC.00208-13. Epub 2013 Mar 4. No abstract available.

7.

Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry.

Sánchez-Moya AI, García-Doval I, Carretero G, Sánchez-Carazo J, Ferrandiz C, Herrera Ceballos E, Alsina M, Ferrán M, López-Estebaranz JL, Gómez-García F, De la Cueva Dobao P, Carrascosa JM, Vanaclocha F, Belinchón I, Peral F, Dauden E; BIOBADADERM Study Group.

J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1366-74. doi: 10.1111/jdv.12011. Epub 2012 Nov 8.

PMID:
23134268
8.

[Microbiological characterisation of Listeria monocytogenes isolates from human cases in Andalusia].

Lepe JA, Torres MJ, Liró J, Luque R, Aznar J; Grupo LISAND-Microbiología.

Enferm Infecc Microbiol Clin. 2012 Dec;30(10):602-7. doi: 10.1016/j.eimc.2012.02.012. Epub 2012 Apr 16. Spanish.

PMID:
22513092
9.

Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials.

Garcia-Doval I, Carretero G, Vanaclocha F, Ferrandiz C, Daudén E, Sánchez-Carazo JL, Alsina M, Herrera-Ceballos E, Gómez-García FJ, Ferrán M, López-Estebaranz JL, Hernanz JM, Belinchón-Romero I, Vilar-Alejo J, Rivera R, Carrascosa JM, Carazo C.

Arch Dermatol. 2012 Apr;148(4):463-70. doi: 10.1001/archdermatol.2011.2768.

PMID:
22508869
10.

Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.

Oteo J, Bautista V, Lara N, Cuevas O, Arroyo M, Fernández S, Lázaro E, de Abajo FJ, Campos J; Spanish ESBL-EARS-Net Study Group.

J Antimicrob Chemother. 2010 Nov;65(11):2459-63. doi: 10.1093/jac/dkq346. Epub 2010 Sep 16.

PMID:
20851815
11.

Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.

Cuevas O, Cercenado E, Gimeno M, Marín M, Coronel P, Bouza E; Spanish Urinary Tract Infection Study Group (SUTIS).

Diagn Microbiol Infect Dis. 2010 Jul;67(3):251-60. doi: 10.1016/j.diagmicrobio.2010.02.013.

PMID:
20542206
12.

[Culture media for the detection and the identification of Streptococcus agalactiae].

de la Rosa M, Pérez M, Carazo C, Pareja L, Orts A, Cantudo P.

Microbiologia. 1994 Mar-Jun;10(1-2):181-6. Spanish.

PMID:
7946121
13.

[Prevalence of antibodies against CMV in Grenada].

Rojo MD, García MV, Oyonarte S, Mendoza J, Carazo C, Fernández-Montoya A.

Sangre (Barc). 1992 Aug;37(4):293-5. Spanish.

PMID:
1325073
14.

New Granada Medium for detection and identification of group B streptococci.

de la Rosa M, Perez M, Carazo C, Pareja L, Peis JI, Hernandez F.

J Clin Microbiol. 1992 Apr;30(4):1019-21.

15.

[Evaluation of the Vitek system in the identification and biotyping of Streptococcus agalactiae].

Carazo C, Cueto M, Miranda C, Peis J, Pérez M, Rosa M.

Enferm Infecc Microbiol Clin. 1991 Feb;9(2):98-9. Spanish.

PMID:
1854857
16.

[Isolation of Streptococcus agalactiae in adults: serotypes, adhesiveness to epithelial cells].

Cueto M, Carazo C, Rojas A, Bañón R, Rosa M.

Enferm Infecc Microbiol Clin. 1990 Aug-Sep;8(7):426-8. Spanish.

PMID:
2152478
17.

Mycoplasma hominis infection in three renal transplant patients.

Miranda C, Carazo C, Bañón R, Mendoza J, Montes A, de la Rosa M.

Diagn Microbiol Infect Dis. 1990 Jul-Aug;13(4):329-31.

PMID:
2076594

Supplemental Content

Loading ...
Support Center